|
Thoracoscopic Lobectomy is Associated with Lower Morbidity than Open Lobectomy: A Propensity-Matched Analysis from the STS Database
|
Subroto Paul1, Nasser K. Altorki1, Shubin Sheng2, Paul C. Lee1, David H. Harpole2, Mark W. Onaitis2, Brendon M. Stiles1, Jeffrey L. Port1, Thomas A. D'Amico2; 1Cardiothoracic Surgery, New York Presbyterian-Weill Cornell Medical Center, New York, NY; 2Duke University Medical Center, Durham, NC
Objective: Thoracoscopic lobectomy, compared to thoracotomy, may be associated with fewer overall postoperative complications based on several single institution series. Propensity matching using a large national database may enable a more powerful and comprehensive analysis of postoperative outcomes. Methods: All patients undergoing lobectomy as the primary procedure via thoracoscopy or thoracotomy were identified in the Society of Thoracic Surgeons (STS) prospective database from 2002-2007. After excluding patients with prior thoracic surgery, 6434 patients were identified (5134 thoracotomy, 1300 thoracoscopy). A propensity analysis was performed, incorporating preoperative variables using a greedy matching algorithm. Results: Propensity scores were calculated based on age, sex, body mass index, functional status, medical co-morbidities, smoking status, pulmonary function tests, and preoperative therapy. Matching based on propensity scores produced 1281 patients in each group for analysis of postoperative outcomes. After thoracoscopic lobectomy, 73.8% (n=945) had no complications, compared to only 65.3% (n=847) after thoracotomy (p<0.0001). Compared to thoracotomy, thoracoscopic lobectomy was associated with a lower incidence of arrhythmias [93 (7.3%) v 147 (11.5%); p=0.0004], reintubation [18 (1.4%) v 40 (3.1%); p=0.0046], and blood transfusion [31 (2.4%) v 60 (4.68%); p=0.0028], as well as a shorter length of stay (4.00 v 6.00 days; p<0.0001) and chest tube duration (3.00 v 4.00 days; p<0.0001; Table). Thoracoscopic lobectomy required longer operative time (173 v. 143 minutes; p<0.05). There was no difference in operative mortality between the 2 groups. Conclusion: Thoracoscopic lobectomy is associated with a lower incidence of many complications compared to thoracotomy. For appropriate candidates, thoracoscopic lobectomy may be the preferred strategy for patients with lung cancer.
TABLE
| Postoperative Complications | Thoracotomy (n=1281) | Thoracoscopy (n=1281) | p Value* | | Atrial Arrhythmia, n (%) | 147 (11.48) | 93 (7.26) | 0.0004 | | Reintubation, n (%) | 40 (3.12) | 18 (1.41) | 0.0046 | | Blood Transfusion, n (%) | 60 (4.68) | 31 (2.42) | 0.0028 | | No complications | 847 (65.3) | 945 (73.8) | <0.0001 | | Air Leak >5 Days, n (%) | 111 (8.67) | 97 (7.57) | 0.3531 | | Pneumonia, n (%) | 56 (4.37) | 38 (2.97) | 0.0758 | | Atelectasis, n (%) | 42 (3.28) | 27 (2.11) | 0.0722 | | Bleeding, n (%) | 7 (0.55) | 16 (1.25) | 0.0931 | | DVT, n (%) | 4 (0.31) | 2 (0.16) | 0.6875 | | Pulmonary Embolus, n (%) | 3 (.23) | 3 (.23) | 1.000 | | Myocardial Infarct, n (%) | 1 (0.08) | 1 (0.08) | 1.000 | | Operative mortality n(%) | 12 (0.94) | 12 (1.01) | 1.000 | | LOS (median), days | 6.00 | 4.00 | <0.0001 | | Chest Tube Duration (median), days | 4.00 | 3.00 | <0.0001 | | OR Time (median), minutes | 143.00 | 173.00 | <0.0001 |
* p-values are based on McNemar tests for categorical outcomes and Wilcoxon signed rank tests for continuous outcomes.
Back to 2009 Annual Meeting
Back to Program Outline
Back to Main Program
|
|